Literature DB >> 26292256

Two Loops Undergoing Concerted Dynamics Regulate the Activity of the ASH1L Histone Methyltransferase.

David S Rogawski1, Juliano Ndoj1, Hyo Je Cho1, Ivan Maillard1, Jolanta Grembecka1, Tomasz Cierpicki1.   

Abstract

ASH1L (absent, small, or homeotic-like 1) is a histone methyltransferase (HMTase) involved in gene activation that is overexpressed in multiple forms of cancer. Previous studies of ASH1L's catalytic SET domain identified an autoinhibitory loop that blocks access of histone substrate to the enzyme active site. Here, we used both nuclear magnetic resonance and X-ray crystallography to identify conformational dynamics in the ASH1L autoinhibitory loop. Using site-directed mutagenesis, we found that point mutations in the autoinhibitory loop that perturb the structure of the SET domain result in decreased enzyme activity, indicating that the autoinhibitory loop is not a simple gate to the active site but is rather a key feature critical to ASH1L function. We also identified a second loop in the SET-I subdomain of ASH1L that experiences conformational dynamics, and we trapped two different conformations of this loop using crystallographic studies. Mutation of the SET-I loop led to a large decrease in ASH1L enzymatic activity in addition to a significant conformational change in the SET-I loop, demonstrating the importance of the structure and dynamics of the SET-I loop to ASH1L function. Furthermore, we found that three C-terminal chromatin-interacting domains greatly enhance ASH1L enzymatic activity and that ASH1L requires native nucleosome substrate for robust activity. Our study illuminates the role of concerted conformational dynamics in ASH1L function and identifies structural features important for ASH1L enzymatic activity.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26292256      PMCID: PMC4664444          DOI: 10.1021/acs.biochem.5b00697

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  48 in total

1.  H3K36 methylation antagonizes PRC2-mediated H3K27 methylation.

Authors:  Wen Yuan; Mo Xu; Chang Huang; Nan Liu; She Chen; Bing Zhu
Journal:  J Biol Chem       Date:  2011-01-14       Impact factor: 5.157

2.  NMRPipe: a multidimensional spectral processing system based on UNIX pipes.

Authors:  F Delaglio; S Grzesiek; G W Vuister; G Zhu; J Pfeifer; A Bax
Journal:  J Biomol NMR       Date:  1995-11       Impact factor: 2.835

3.  miR-142-3p down-regulation contributes to thyroid follicular tumorigenesis by targeting ASH1L and MLL1.

Authors:  Marianna Colamaio; Francesca Puca; Elvira Ragozzino; Marica Gemei; Myriam Decaussin-Petrucci; Concetta Aiello; André Uchimura Bastos; Antonella Federico; Gennaro Chiappetta; Luigi Del Vecchio; Liborio Torregrossa; Sabrina Battista; Alfredo Fusco
Journal:  J Clin Endocrinol Metab       Date:  2015-01       Impact factor: 5.958

4.  Fluorescence analysis of a dynamic loop in the PCAF/GCN5 histone acetyltransferase.

Authors:  Yujun Zheng; Fatemah Mamdani; Dimitri Toptygin; Ludwig Brand; James T Stivers; Philip A Cole
Journal:  Biochemistry       Date:  2005-08-09       Impact factor: 3.162

5.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

Review 6.  Diverse functions of PHD fingers of the MLL/KMT2 subfamily.

Authors:  Muzaffar Ali; Robert A Hom; Weston Blakeslee; Larissa Ikenouye; Tatiana G Kutateladze
Journal:  Biochim Biophys Acta       Date:  2013-11-28

7.  The BAH domain of Rsc2 is a histone H3 binding domain.

Authors:  Anna L Chambers; Laurence H Pearl; Antony W Oliver; Jessica A Downs
Journal:  Nucleic Acids Res       Date:  2013-07-31       Impact factor: 16.971

Review 8.  Use of epigenetic drugs in disease: an overview.

Authors:  Sarah Heerboth; Karolina Lapinska; Nicole Snyder; Meghan Leary; Sarah Rollinson; Sibaji Sarkar
Journal:  Genet Epigenet       Date:  2014-05-27

9.  MolProbity: all-atom structure validation for macromolecular crystallography.

Authors:  Vincent B Chen; W Bryan Arendall; Jeffrey J Headd; Daniel A Keedy; Robert M Immormino; Gary J Kapral; Laura W Murray; Jane S Richardson; David C Richardson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-12-21

10.  Genome and transcriptome sequencing of lung cancers reveal diverse mutational and splicing events.

Authors:  Jinfeng Liu; William Lee; Zhaoshi Jiang; Zhongqiang Chen; Suchit Jhunjhunwala; Peter M Haverty; Florian Gnad; Yinghui Guan; Houston N Gilbert; Jeremy Stinson; Christiaan Klijn; Joseph Guillory; Deepali Bhatt; Steffan Vartanian; Kimberly Walter; Jocelyn Chan; Thomas Holcomb; Peter Dijkgraaf; Stephanie Johnson; Julie Koeman; John D Minna; Adi F Gazdar; Howard M Stern; Klaus P Hoeflich; Thomas D Wu; Jeff Settleman; Frederic J de Sauvage; Robert C Gentleman; Richard M Neve; David Stokoe; Zora Modrusan; Somasekar Seshagiri; David S Shames; Zemin Zhang
Journal:  Genome Res       Date:  2012-10-02       Impact factor: 9.043

View more
  11 in total

Review 1.  H3K36 methyltransferases as cancer drug targets: rationale and perspectives for inhibitor development.

Authors:  David S Rogawski; Jolanta Grembecka; Tomasz Cierpicki
Journal:  Future Med Chem       Date:  2016-08-22       Impact factor: 3.808

2.  Dynamic behavior of the post-SET loop region of NSD1: Implications for histone binding and drug development.

Authors:  Sarah E Graham; Sara E Tweedy; Heather A Carlson
Journal:  Protein Sci       Date:  2016-03-31       Impact factor: 6.725

3.  The molecular genetic make-up of male breast cancer.

Authors:  Cathy B Moelans; Joep de Ligt; Petra van der Groep; Pjotr Prins; Nicolle J M Besselink; Marlous Hoogstraat; Natalie D Ter Hoeve; Miangela M Lacle; Robert Kornegoor; Carmen C van der Pol; Wendy W J de Leng; Ellis Barbé; Bert van der Vegt; John Martens; Peter Bult; Vincent T H B M Smit; Marco J Koudijs; Isaac J Nijman; Emile E Voest; Pier Selenica; Britta Weigelt; Jorge S Reis-Filho; Elsken van der Wall; Edwin Cuppen; Paul J van Diest
Journal:  Endocr Relat Cancer       Date:  2019-10       Impact factor: 5.678

Review 4.  Exploring Methods of Targeting Histone Methyltransferases and Their Applications in Cancer Therapeutics.

Authors:  Michelle Y Wang; Priscilla Liow; Maria I Tarazona Guzman; Jun Qi
Journal:  ACS Chem Biol       Date:  2022-04-01       Impact factor: 4.634

5.  Discovery of first-in-class inhibitors of ASH1L histone methyltransferase with anti-leukemic activity.

Authors:  David S Rogawski; Jing Deng; Hao Li; Hongzhi Miao; Dmitry Borkin; Trupta Purohit; Jiho Song; Jennifer Chase; Shuangjiang Li; Juliano Ndoj; Szymon Klossowski; EunGi Kim; Fengbiao Mao; Bo Zhou; James Ropa; Marta Z Krotoska; Zhuang Jin; Patricia Ernst; Xiaomin Feng; Gang Huang; Kenichi Nishioka; Samantha Kelly; Miao He; Bo Wen; Duxin Sun; Andrew Muntean; Yali Dou; Ivan Maillard; Tomasz Cierpicki; Jolanta Grembecka
Journal:  Nat Commun       Date:  2021-05-14       Impact factor: 14.919

6.  Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome.

Authors:  Michael Tellier; Ronald Chalmers
Journal:  Nucleic Acids Res       Date:  2019-01-10       Impact factor: 16.971

7.  A loss-of-function variant in SUV39H2 identified in autism-spectrum disorder causes altered H3K9 trimethylation and dysregulation of protocadherin β-cluster genes in the developing brain.

Authors:  Shabeesh Balan; Yoshimi Iwayama; Tetsuo Ohnishi; Mikiko Fukuda; Atsuko Shirai; Ayumi Yamada; Sara Weirich; Maren Kirstin Schuhmacher; Kalarickal Vijayan Dileep; Toshihiro Endo; Yasuko Hisano; Kaoru Kotoshiba; Tomoko Toyota; Takeshi Otowa; Hitoshi Kuwabara; Mamoru Tochigi; Akiko Watanabe; Hisako Ohba; Motoko Maekawa; Manabu Toyoshima; Tsukasa Sasaki; Kazuhiko Nakamura; Masatsugu Tsujii; Hideo Matsuzaki; Kam Y J Zhang; Albert Jeltsch; Yoichi Shinkai; Takeo Yoshikawa
Journal:  Mol Psychiatry       Date:  2021-07-15       Impact factor: 15.992

8.  Identification of a peptide inhibitor for the histone methyltransferase WHSC1.

Authors:  Michael J Morrison; P Ann Boriack-Sjodin; Kerren K Swinger; Tim J Wigle; Dipti Sadalge; Kevin W Kuntz; Margaret Porter Scott; William P Janzen; Richard Chesworth; Kenneth W Duncan; Darren M Harvey; John W Lampe; Lorna H Mitchell; Robert A Copeland
Journal:  PLoS One       Date:  2018-05-09       Impact factor: 3.240

9.  Mrg15 stimulates Ash1 H3K36 methyltransferase activity and facilitates Ash1 Trithorax group protein function in Drosophila.

Authors:  Chang Huang; Fu Yang; Zhuqiang Zhang; Jing Zhang; Gaihong Cai; Lin Li; Yong Zheng; She Chen; Rongwen Xi; Bing Zhu
Journal:  Nat Commun       Date:  2017-11-21       Impact factor: 14.919

10.  Effect of H2A.Z deletion is rescued by compensatory mutations in Fusarium graminearum.

Authors:  Zhenhui Chen; Enric Zehraoui; Anna K Atanasoff-Kardjalieff; Joseph Strauss; Lena Studt; Nadia Ponts
Journal:  PLoS Genet       Date:  2020-10-22       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.